{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T19:17:47Z","timestamp":1757704667083,"version":"3.37.3"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T00:00:00Z","timestamp":1711670400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008363","name":"Danish Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008363","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.ctro.2024.100772","type":"journal-article","created":{"date-parts":[[2024,3,30]],"date-time":"2024-03-30T07:15:23Z","timestamp":1711782923000},"page":"100772","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["High-dose loco-regional pattern of failure after primary radiotherapy in p16 positive and negative head and neck squamous cell carcinoma \u2013 A DAHANCA 19 study"],"prefix":"10.1016","volume":"46","author":[{"given":"Morten Horsholt","family":"Kristensen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne Ivalu Sander","family":"Holm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian R\u00f8nn","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0915-6880","authenticated-orcid":false,"given":"Ruta","family":"Zukauskaite","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8011-669X","authenticated-orcid":false,"given":"Eva","family":"Sams\u00f8e","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9698-2082","authenticated-orcid":false,"given":"Christian","family":"Maare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f8rgen","family":"Johansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanne","family":"Primdahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c5se","family":"Bratland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claus Andrup","family":"Kristensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Overgaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesper Grau","family":"Eriksen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctro.2024.100772_b0005","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3109\/0284186X.2015.1117136","article-title":"Failure pattern and salvage treatment after radical treatment of head and neck cancer","volume":"55","author":"Pagh","year":"2016","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ctro.2024.100772_b0010","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.semcancer.2017.02.011","article-title":"Cancer stem cells: The root of tumor recurrence and metastases","volume":"44","author":"Peitzsch","year":"2017","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.ctro.2024.100772_b0015","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nrc2419","article-title":"Exploring the role of cancer stem cells in radioresistance","volume":"8","author":"Baumann","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ctro.2024.100772_b0020","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.radonc.2013.06.011","article-title":"Radiosensitivity and effect of hypoxia in HPV positive head and neck cancer cells","volume":"108","author":"S\u00f8rensen","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2024.100772_b0025","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrc.2016.18","article-title":"Radiation oncology in the era of precision medicine","volume":"16","author":"Baumann","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ctro.2024.100772_b0030","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.radonc.2014.11.032","article-title":"Impact of HPV-associated p16-expression on radiotherapy outcome in advanced oropharynx and non-oropharynx cancer","volume":"113","author":"Lassen","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2024.100772_b0035","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1002\/hed.25586","article-title":"Failure patterns of head and neck squamous cell carcinoma treated with radical radiotherapy by intensity modulated radiotherapy technique using focal volume and dosimetric method","volume":"41","author":"Tandon","year":"2019","journal-title":"Head Neck"},{"key":"10.1016\/j.ctro.2024.100772_b0040","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.oraloncology.2019.03.013","article-title":"Reducing radiotherapy target volume expansion for patients with HPV-associated oropharyngeal cancer","volume":"92","author":"Burr","year":"2019","journal-title":"Oral Oncol"},{"key":"10.1016\/j.ctro.2024.100772_b0045","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ijrobp.2012.02.042","article-title":"Origin of tumor recurrence after intensity modulated radiation therapy for oropharyngeal squamous cell carcinoma","volume":"85","author":"Raktoe","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2024.100772_b0050","first-page":"139","article-title":"Recurrence of head and neck squamous cell carcinoma in relation to high-risk treatment volume","volume":"27","author":"Nissi","year":"2021","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.ctro.2024.100772_b0055","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13014-015-0345-4","article-title":"Assessment and topographic characterization of locoregional recurrences in head and neck tumours","volume":"10","author":"Ferreira","year":"2015","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ctro.2024.100772_b0060","article-title":"Local failure rate in oropharyngeal carcinoma patients treated with intensity-modulated radiotherapy without high-dose clinical target volume","volume":"10","author":"Almarzouki","year":"2018","journal-title":"Cureus"},{"key":"10.1016\/j.ctro.2024.100772_b0065","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.radonc.2017.11.024","article-title":"Local recurrences after curative IMRT for HNSCC: Effect of different GTV to high-dose CTV margins","volume":"126","author":"Zukauskaite","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2024.100772_b0070","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1007\/s00405-016-4413-7","article-title":"Recurrent oropharyngeal cancer after organ preserving treatment: pattern of failure and survival","volume":"274","author":"de Ridder","year":"2017","journal-title":"Eur Arch Oto-Rhino-Laryngol"},{"key":"10.1016\/j.ctro.2024.100772_b0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13014-017-0868-y","article-title":"Patterns of locoregional failure following post-operative intensity-modulated radiotherapy to oral cavity cancer: quantitative spatial and dosimetric analysis using a deformable image registration workflow","volume":"12","author":"Mohamed","year":"2017","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ctro.2024.100772_b0080","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1080\/0284186X.2017.1346384","article-title":"Analysis of CT-verified loco-regional recurrences after definitive IMRT for HNSCC using site of origin estimation methods","volume":"56","author":"Zukauskaite","year":"2017","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ctro.2024.100772_b0085","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.oraloncology.2015.08.004","article-title":"Analysis of loco-regional failures in head and neck cancer after radical radiation therapy","volume":"51","author":"De Felice","year":"2015","journal-title":"Oral Oncol"},{"key":"10.1016\/j.ctro.2024.100772_b0090","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.clon.2014.05.001","article-title":"Patterns of failure after intensity-modulated radiotherapy in head and neck squamous cell carcinoma using compartmental clinical target volume delineation","volume":"26","author":"Bayman","year":"2014","journal-title":"Clin Oncol"},{"key":"10.1016\/j.ctro.2024.100772_b0095","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.radonc.2014.06.001","article-title":"Recurrences after intensity modulated radiotherapy for head and neck squamous cell carcinoma more likely to originate from regions with high baseline [18F]-FDG uptake","volume":"111","author":"Due","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2024.100772_b0100","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.radonc.2017.07.017","article-title":"Patterns-of-failure guided biological target volume definition for head and neck cancer patients: FDG-PET and dosimetric analysis of dose escalation candidate subregions","volume":"124","author":"Mohamed","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2024.100772_b0105","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.radonc.2017.04.015","article-title":"Inadequate target volume delineation and local\u2013regional recurrence after intensity-modulated radiotherapy for human papillomavirus-positive oropharynx cancer: Local\u2013regional recurrence after IMRT for HPV-positive oropharynx cancer","volume":"123","author":"Chen","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2024.100772_b0110","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1001\/jamaoncol.2017.0973","article-title":"Patterns of treatment failure and postrecurrence outcomes among patients with locally advanced head and neck squamous cell carcinoma after chemoradiotherapy using modern radiation techniques","volume":"3","author":"Leeman","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ctro.2024.100772_b0115","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.ijrobp.2013.11.021","article-title":"Evaluation of the EGFR-inhibitor zalutumumab given with primary curative (chemo)radiation therapy to patients with squamous cell carcinoma of the head and neck: results of the DAHANCA 19 randomized phase 3 trial","volume":"88","author":"Eriksen","year":"2014","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.ctro.2024.100772_b0120","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.radonc.2003.09.011","article-title":"CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC, RTOG consensus guidelines","volume":"69","author":"Gr\u00e9goire","year":"2003","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2024.100772_b0125","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/0284186X.2017.1406140","article-title":"DBCG hypo trial validation of radiotherapy parameters from a national data bank versus manual reporting","volume":"57","author":"Brink","year":"2018","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ctro.2024.100772_b0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1088\/1742-6596\/489\/1\/012100","article-title":"A DICOM based radiotherapy plan database for research collaboration and reporting","volume":"489","author":"Westberg","year":"2014","journal-title":"J Phys Conf Ser"},{"key":"10.1016\/j.ctro.2024.100772_b0135","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s00066-016-0998-4","article-title":"Open source deformable image registration system for treatment planning and recurrence CT scans: validation in the head and neck region","volume":"192","author":"Zukauskaite","year":"2016","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.ctro.2024.100772_b0140","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.phro.2022.06.012","article-title":"Co-registration of radiotherapy planning and recurrence scans with different imaging modalities in head and neck cancer","volume":"23","author":"Kristensen","year":"2022","journal-title":"Phys Imaging Radiat Oncol"},{"key":"10.1016\/j.ctro.2024.100772_b0145","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.semradonc.2021.02.009","article-title":"Biology of the radio- and chemo-responsiveness in HPV malignancies","volume":"31","author":"Spiotto","year":"2021","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.ctro.2024.100772_b0150","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.radonc.2013.03.013","article-title":"HNSCC cell lines positive for HPV and p16 possess higher cellular radiosensitivity due to an impaired DSB repair capacity","volume":"107","author":"Rieckmann","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2024.100772_b0155","first-page":"40","article-title":"Independent validation of tumour volume, cancer stem cell markers and hypoxia-associated gene expressions for HNSCC after primary radiochemotherapy","volume":"16","author":"Linge","year":"2019","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.ctro.2024.100772_b0160","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1080\/09553000902836404","article-title":"Cancer stem cells and radiotherapy","volume":"85","author":"Baumann","year":"2009","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.ctro.2024.100772_b0165","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S0360-3016(99)00550-7","article-title":"Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer","volume":"46","author":"Dawson","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2024.100772_b0170","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1080\/0284186X.2019.1629015","article-title":"Distinguishing recurrence and new primary tumor as well as the origin of neck metastases in head and neck cancer clinical trials by targeted DNA sequencing","volume":"58","author":"Lilja-Fischer","year":"2019","journal-title":"Acta Oncol"}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630824000491?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630824000491?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T22:05:51Z","timestamp":1724969151000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405630824000491"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":34,"alternative-id":["S2405630824000491"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2024.100772","relation":{},"ISSN":["2405-6308"],"issn-type":[{"type":"print","value":"2405-6308"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-dose loco-regional pattern of failure after primary radiotherapy in p16 positive and negative head and neck squamous cell carcinoma \u2013 A DAHANCA 19 study","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2024.100772","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}],"article-number":"100772"}}